Position in XGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,393,638
+$780,028 QoQ
Shares Held
514,761
-4.3% QoQ
Ownership
2.12%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#5
of 57 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 66%
Shared 0%
None 34%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SILVERCREST ASSET MANAGEMENT GROUP LLC holds $153,900,221 across 13 Diagnostics & Research names. XGN ranks #9 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
104,046 | $52,164,502 | |
| 2 | DGX |
Quest Diagnostics Inc
|
126,888 | $26,893,911 | |
| 3 | RDNT |
RadNet, Inc.
|
351,756 | $21,692,792 | |
| 4 | DHR |
Danaher Corp /De/
|
98,198 | $18,704,755 | |
| 5 | A |
Agilent Technologies, Inc.
|
79,608 | $10,574,330 | |
| 6 | CDNA |
CareDx, Inc.
|
296,200 | $8,441,700 | |
| 7 | CSTL |
Castle Biosciences Inc
|
256,095 | $6,107,865 | |
| 8 | LH |
Labcorp Holdings Inc.
|
18,131 | $5,076,680 |
All Filings in XGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,393,638 | 514,761 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,613,610 | 537,870 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,635,353 | 597,920 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,708,953 | 519,468 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,711,733 | 531,767 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,909,043 | 531,767 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,193,569 | 535,017 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,671,343 | 540,888 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $991,676 | 544,877 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $866,354 | 544,877 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,084,305 | 544,877 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,318,602 | 544,877 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,586,685 | 547,133 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,221,354 | 502,615 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,206,276 | 502,615 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,374,262 | 507,108 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,844,675 | 495,588 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,156,464 | 517,617 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,964,910 | 512,890 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,975,304 | 512,890 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,649,868 | 310,198 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,450,462 | 311,455 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||